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Electrocardiographic characteristics at initial diagnosis in
patients with isolated left ventricular noncompaction
Abstract
Isolated ventricular noncompaction (IVNC) is a primary cardiomyopathy characterized by a specific
morphologic pattern. Patients with IVNC may suffer from various arrhythmic complications such as
life-threatening ventricular arrhythmias, as well as heart failure or systemic embolic events. The present
study was designed to comprehensively analyze the ECG pattern at the time of initial diagnosis in
patients with IVNC, and to investigate their correlation with clinical features and echocardiographic
findings. ECGs from the time of initial diagnosis of IVNC were available in 78 patients between March
1995 and November 2008. The most common findings were intraventricular conduction delay
(especially left bundle branch block), voltage signs of left ventricular (LV) hypertrophy, and
repolarisation abnormalities. An entirely normal ECG was only present in 10 subjects (13%). However,
no ECG findings or patterns specific for IVNC were found. A striking overlap was observed between
the presence of intraventricular conduction delay (left bundle branch block, in particular), atrial
conduction delay (PR interval prolongation or AV-block), and prolongation of the QTc on the one hand,
and reduced systolic LV function and LV / left atrial dilation on the other. Moreover, patients with
electrocardiographic voltage signs of LV hypertrophy more often presented with or had a history of
systemic embolic events. In conclusion, our study provides a comprehensive analysis of ECG findings
of patients newly diagnosed with IVNC; while intraventricular conduction delay, repolarisation
abnormalities and LV hypertrophy are frequently present, no ECG patterns are specific for IVNC at the
time of first presentation with the disease. Whether these findings indeed have prognostic implications
needs to be investigated in long-term controlled studies.
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Abstract 
 
Isolated ventricular noncompaction (IVNC) is a primary cardiomyopathy characterized by a 
specific morphologic pattern. Patients with IVNC may suffer from various arrhythmic 
complications such as life-threatening ventricular arrhythmias, as well as heart failure or systemic 
embolic events. The present study was designed to comprehensively analyze the ECG pattern at the 
time of initial diagnosis in patients with IVNC, and to investigate their correlation with clinical 
features and echocardiographic findings. ECGs from the time of initial diagnosis of IVNC were 
available in 78 patients between March 1995 and November 2008. The most common findings were 
intraventricular conduction delay (especially left bundle branch block), voltage signs of left 
ventricular (LV) hypertrophy, and repolarisation abnormalities. An entirely normal ECG was only 
present in 10 subjects (13%). However, no ECG findings or patterns specific for IVNC were found. 
A striking overlap was observed between the presence of intraventricular conduction delay (left 
bundle branch block, in particular), atrial conduction delay (PR interval prolongation or AV-block), 
and prolongation of the QTc on the one hand, and reduced systolic LV function and LV / left atrial 
dilation on the other. Moreover, patients with electrocardiographic voltage signs of LV hypertrophy 
more often presented with or had a history of systemic embolic events. In conclusion, our study 
provides a comprehensive analysis of ECG findings of patients newly diagnosed with IVNC; while 
intraventricular conduction delay, repolarisation abnormalities and LV hypertrophy are frequently 
present, no ECG patterns are specific for IVNC at the time of first presentation with the disease. 
Whether these findings indeed have prognostic implications needs to be investigated in long-term 
controlled studies.  
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Introduction 
 
 Isolated ventricular noncompaction (IVNC) is a primary cardiomyopathy1 characterized by a 
two-layered structure of the myocardium with a thin, compacted epicardial layer and a severely 
thickened, non-compacted endocardial layer consisting of a trabecular meshwork with deep 
endocardial spaces, which by definition occur in the absence of any other coexisting congenital 
lesions.2, 3 Patients with IVNC can present with a wide clinical spectrum varying from coincidental 
discovery in asymptomatic patients to severe heart failure at the other end of the spectrum.3 
Depending on the initial presentation, the natural history of the disease in symptomatic patients is 
grim; indeed, we previously showed that during long-term follow up of 44 months, 35% of patients 
died (half of them because of sudden cardiac death), while ventricular tachycardia (VT) occurred in 
41% of patients in that series.4, 5  In the same report, an abnormal ECG was found in 94% of the 
cases, with conduction block (left or right bundle branch block) as well as repolarisation 
abnormalities being the most frequent findings.4 To date, however, no systematic analysis of 
electrocardiographic features in patients newly diagnosed with IVNC has been performed. The 
purpose of the present study therefore was to analyze and to describe ECG patterns at the time of 
initial diagnosis, and to correlate them to echocardiographic findings and clinical presentation. 
 
 
Methods 
 
All patients first diagnosed with IVNC at the University Hospital Zurich or referred to the 
University Hospital of Zurich for confirmation of suspected IVNC were included, if an ECG from 
the time of first diagnosis was available. In our large cohort of patients diagnosed with IVNC 
between January 1995 and November 2008, baseline ECGs from the time of first diagnosis of the 
disease were available in 78 out of 102 cases. In the remainder, patient files were either too old or 
no ECG from the time of initial diagnosis of IVNC was available. ECGs were independently 
analyzed by two readers (JS and FD). Standard criteria for ECG findings were applied, including: 
first degree atrioventricular block (PR interval  200msec); p mitrale (p-wave duration  0.11sec 
and biphasic p-wave in V1); p pulmonale (p-wave voltage  0.2mV in leads II and III); voltage 
criteria for left ventricular (LV) hypertrophy (S in V1 or V2 (whichever is largest) + R in V5 or V6 
(whichever is largest)  3.5mV); voltage criteria for right ventricular (RV) hypertrophy (R in V1 or 
V2 (whichever is largest) + S in V5 or V6 (whichever is largest)  1.05mV); and QTc prolongation 
(QTc  450msec for men and ≥ 470msec for women).  
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Ninety four percent of echocardiographies were performed, directly supervised, or 
independently confirmed by RJ and EO. Echocardiographic criteria for the diagnosis of IVNC were 
the same as previously published3, 4 and remained unchanged during the entire study period: 1) The 
absence of coexisting cardiac anomalies (other than 2–4); 2) Two-layered structure of the 
myocardium with a thin, compacted epicardial layer and a much thicker, non-compacted 
endocardial layer consisting of a trabecular meshwork with deep endocardial spaces, and a 
maximum end systolic ratio of the non-compacted endocardial layer to the compacted myocardium 
of ≥2, measured at end-systole; 3) Predominant segmental location of the abnormality; and 4) 
colour Doppler-echocardiographic evidence of deep intertrabecular recesses perfused with blood 
from the left ventricular cavity (Fig. 1). To describe precisely the location of the affected segments, 
the left ventricle was divided into nine segments: one apical segment, four midventricular segments 
(inferior, lateral, anterior, septal, localized between the apical segment and the papillary muscle) 
and four basal segments (inferior, lateral, anterior, septal, localized between the papillary muscle 
and the base).3, 4 Importantly, patients with other congenital structural cardiac anomalies (e.g., 
Ebstein’s disease, tetralogy of Fallot) were excluded from the analysis as they by definition do not 
fulfill criteria of isolated non-compaction cardiomyopathy. At our center, we furthermore do not 
attempt the diagnosis of right ventricular noncompaction anymore, as it may be difficult if not 
impossible to exactly differentiate between normal variants of the usually highly trabeculated right 
ventricle and pathological forms.3, 4, 6 The study was approved by the Cantonal Ethics Committee of 
Zurich.  
Comparison of categorical variables was performed by Chi-square and Fisher's exact test (in 
case of low sample sizes). Continuous variables were analyzed by two-sided Student’s t-test (for 
normally distributed variables) or Mann-Whitney U test (for non-normally distributed variables). A 
p-value < 0.05 was considered significant. To investigate potential associations, subgroups were 
analyzed and correlated according to ECG findings, clinical presentation, and echocardiographic 
findings. Only significant associations are reported; findings judged self-explanatory or trivial (such 
as, repolarisation abnormalities in patients with bundle branch block, etc.) were not reported to 
avoid distraction from the main findings.  
 
 
Results 
 
Mean age of patients at the time of diagnosis was 42 years (+/- 16 years), 71% of patients 
were men. Most patients (33%) initially presented with heart failure, followed by syncope (14%), 
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coincidental discovery of the disease (13%) and diagnosis during family screening (5%). Six 
patients (8%) first presented with ventricular tachycardia (VT), ventricular fibrillation (VF) or 
pulseless electrical activity; not counted in these are 2 patients who had to be resuscitated due to 
severe subarachnoid hemorrhage following rupture of a cerebral aneurysm, and in whom IVNC was 
diagnosed by coincidence during echocardiography. Six patients (8%) first presented with a 
systemic embolic event, during evaluation of which IVNC was diagnosed, and 10 patients (13%) 
had a history of systemic embolism. At presentation, 22, 7, and 6 patients were on beta-blocker, 
digoxin, and amiodarone therapy, respectively. Five patients had arterial hypertension. Thirty two 
patients underwent coronary angiography during workup of their disease, and significant coronary 
artery disease was diagnosed in 5 patients (16%). 
Patients’ ECG findings at the time of first diagnosis of IVNC are summarized in table 1; 
most common ECG findings are shown in figures 2 & 3. One patient, who had a permanent 
pacemaker in place due to third degree AV block, was omitted from further ECG analysis because 
of the artificial QRS and ST morphology resulting from right ventricular pacing   
Echocardiographic findings are summarized in table 2. The LV apex was most often 
affected (69 patients, 89%). Of the remaining wall segments, midventricular lateral and 
midventricular inferior wall involvement was most common. The average number of affected LV 
segments per patient was 2.4. LV systolic dysfunction as well as left atrial and ventricular dilation 
were common, which mostly occurred in the clinical setting of congestive heart failure. Valvular 
pathologies were common, while severe valvulopathies on the other hand were rare.  
Analyses of subgroups according to clinical presentation are summarized in table 3. When 
systemic embolism was the reason for presentation or had been present in the past, ECGs more 
often showed voltage signs of LV hypertrophy (70% vs. 34%, p = 0.039); in contrast, 
echocardiographic parameters (including LV ejection fraction (EF), atrial size, pattern of IVNC 
involvement) were similar as compared to the rest of the cohort.  
Analyses of subgroups according to ECG findings are summarized in table 4. As expected, 
LVEF was significantly better in patients with a normal ECG, and they were less likely to present 
with structural abnormalities such as LV/LA/RA dilation (data not shown); a similar pattern of LV 
segment involvement was observed as compared to the entire cohort. Of the 30 patients with 
electrocardiographic voltage signs of LV hypertrophy, only 3 had posterior or septal wall 
thickening  1.2cm, which was not different from the rest of the cohort (p=0.23); in contrast, the 
LV end-diastolic diameter (EDD) in these patients was significantly larger, and LVEF was reduced. 
Interestingly, patients with voltage signs of LV hypertrophy more often presented with or had a 
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history of systemic embolism. Patients with voltage signs of RVH on ECG neither showed genuine 
RVH nor RV dilation on echocardiography (data not shown). 
 Repolarisation abnormalities mostly occurred secondary to a pathologic depolarization in 
the context of bundle branch block (BBB) or electrocardiographic voltage signs of LV hypertrophy. 
Patients with repolarisation abnormalities in the septal, anterior, lateral or inferior leads had 
affection of the respective LV wall (midventricular or basal segment) in 25% (1/4), 8% (3/36), 50% 
(18/36) and 57% (12/21) of cases. When the 15 patients (19%) with isolated repolarisation 
abnormalities (i.e., repolarisation abnormalities in the absence of BBB or electrocardiographic 
voltage signs of LV hypertrophy) were analyzed, no specific echocardiographic correlation or 
pattern of non-compacted LV segments could be detected.  
Analyses of subgroups according to echocardiographic findings are summarized in table 5. 
Patients presenting with posterior or septal wall thickening did not show any specific ECG 
abnormalities (including electrocardiographic voltage signs of LV hypertrophy). No specific ECG 
abnormalities were observed in the subgroups of patients with valvular pathologies (data not 
shown). 
No specific ECG pattern was observed in patients with isolated apical involvement; 
however, these patients were significantly less likely to present with signs and symptoms of heart 
failure. There was no correlation between specific LV segment involvement and any ECG 
abnormalities. In patients with septal, anterior, lateral, or inferior wall involvement (each 
midventricular or basal segment) on echocardiography, repolarisation abnormalities in the 
respective ECG leads were found in 20% (1/5), 38% (3/8), 45% (18/40), and 30% (12/40) of cases. 
No specific ECG changes were observed in patients with 2, 3, 4, or 5 affected LV segments. 
In the subgroup of patients with an LVEF ≤ 30%, no particular pattern of LV segment 
involvement was observed; instead and as expected, features typically accompanying a severely 
reduced LVEF such as LA-, RA-, and LV enlargement were present (data not shown). None of the 
subjects with LVEF ≤ 30% had a normal ECG (p<0.01). 
 
 
Discussion 
 
In contrast to other recent and older studies describing the morphologic feature and 
examining prognostic indicators and follow-up of patients with IVNC,4, 7, 8 the present study was 
designed to comprehensively analyze ECG patterns at the time of initial diagnosis and to correlate 
these findings with echocardiography and clinical presentation at the time of first diagnosis of the 
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disease. The most common findings in initial ECGs were intraventricular conduction delay 
(especially LBBB), electrocardiographic voltage signs of LV hypertrophy, and repolarisation 
abnormalities. An entirely normal ECG was rare (12.8% of our subjects); these patients were 
significantly younger, had less severe structural cardiac abnormalities (except for IVNC), and were 
less likely to present with signs of heart failure. The percentage of normal ECGs is slightly higher 
than that reported in our previous study,4 which may be explained by the different patient 
population as well as by the inclusion of  asymptomatic family members of affected patients during 
family screening. 
Heart failure was the most common presenting symptom at initial evaluation. These patients 
were older, more frequently had more than one LV segment affected by IVNC, and more frequently 
had evidence of other structural abnormalities. A striking overlap was observed between the 
presence of a reduced LVEF, LV / left atrial dilation, and presentation with signs and symptoms of 
CHF on the one hand, and electrocardiographic findings of intraventricular conduction delay 
(LBBB, in particular), atrial conduction delay (i.e. PR interval prolongation or AV-block), and 
prolonged QTc duration on the other hand. While the presence of IVNC most likely led to the 
development of heart failure in these subjects, the concomitantly observed ECG changes are 
typically also seen at the advanced stage in other cardiomyopathies,9 and are hence more likely to 
reflect the severity of the diseased heart in itself, independent of IVNC.  
Patients with IVNC are prone to develop malignant arrhythmias, such as VT and ventricular 
fibrillation (VF).10, 11 Indeed, we recently reported on 12 patients with IVNC receiving an 
implantable cardioverter-defibrillator (ICD) for primary or secondary prevention, which effectively 
treated potentially life-threatening arrhythmias in these patients.10 In the current study, 6 patients 
presented with either VT, VF, or asystole; two of these patients (as compared to none in the rest of 
the cohort) had RBBB, which may indicate a higher risk for such an event in the presence of 
RBBB, but which may also be a result of play of chance given the low absolute number of affected 
individuals. No other ECG abnormalities or specific findings on echocardiography (especially 
regarding the pattern of LV segment involvement) were observed. Patients presenting with syncope 
or presyncope (which equally may be associated with arrhythmias) were less likely to have clinical 
or echocardiographic signs of heart failure; however, also in these patients, no specific ECG 
findings could be detected. Thus, neither specific echocardiographic nor ECG findings (except for 
RBBB) at baseline are associated with a history of malignant arrhythmias or (pre-) syncope, 
underlining the necessity for further studies in this population and alternative strategies (such as 
invasive electrophysiologic testing) for arrhythmia risk stratification. 
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Repolarisation abnormalities occurred frequently in our cohort. Although it would have been 
conceivable that morphologic wall changes in the context of IVNC lead to disturbed repolarisation 
in the corresponding ECG leads, only a moderate degree of correlation was observed in our cohort. 
Similarly, no specific segmental involvement was observed in patients with intraventricular 
conduction abnormalities or LBBB. Hence, no specific ECG abnormalities allowed to derive either 
the degree or the localization of affected LV segments in our patients. 
Apical involvement is a common finding in IVNC.4, 8 In our study, patients with isolated 
affection of the LV apex were less likely to present with clinical signs of heart failure, but did not 
show specific ECG pathologies (especially not with respect to the presence or localization of 
repolarisation abnormalities).  
Electrocardiographic voltage signs of LV hypertrophy were frequently observed in our 
cohort, which, however, did not correlate with posterior or septal wall thickening on 
echocardiography, but rather with an increased LVEDD. Vice versa, patients with posterior or 
septal wall thickening on echocardiography (i.e., signs of LV hypertrophy in addition to the non-
compacted segments) did not show any specific ECG abnormalities, including electrocardiographic 
voltage signs of LV hypertrophy. These findings are not necessarily surprising, since using 
electrocardiographic voltage criteria for LV hypertrophy (i.e., the presence of “tall” QRS complexes 
in the chest leads) does not allow to differentiate between genuine LV hypertrophy and LV 
dilatation9 or an effect of the noncompaction itself.  
Patients with electrocardiographic voltage signs of LV hypertrophy more often presented 
with or had a history of systemic embolic events; vice versa, patients with a history of systemic 
embolic events more frequently presented with electrocardiographic signs of LV hypertrophy. 
These data imply that the presence of voltage signs of LV hypertrophy may be indicative of 
particularly profound alterations in the myocardial structure due to IVNC, which may predispose to 
the development of intraventricular thrombi and subsequent systemic embolic events. Indeed, 
patients with IVNC are known to be at an increased risk of embolic events.3 In view of the rather 
small sample size as well as the “borderline” significant p-values, however, confirmatory analyses 
in other large cohorts as well as prospective studies are needed to further substantiate this 
hypothesis. 
 Notably, two patients in our adult cohort (aged 16 and 33 years) presented with preexcitation 
and Wolf-Parkinson-White Syndrome (WPW). This is remarkable, since WPW is frequently 
observed in children with noncompaction (probably due to an interruption of the normal process of 
development in the fibrous annulus),12 but has not been observed in 2 large cohorts of adult patients 
with IVNC.4, 8 The first patient had isolated apical affection of IVNC and was diagnosed by 
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coincidence, while the second (with apical and lateral wall involvement) suffered a motor vehicle 
accident with craniocerebral injury, in the context of which both the WPW syndrome as well as 
IVNC were diagnosed. No other echocardiographic or electrocardiographic abnormalities were 
observed in these two subjects.  
 
 
Limitations 
 
 The current study comprehensively analyses ECG findings in a large cohort of patients 
newly diagnosed with IVNC. Our data are limited by the retrospective nature of our analysis, by the 
inherent potential selection bias of patients diagnosed at or referred to a tertiary center, and by the 
lack of a matched control population. Furthermore, cardioactive medication as well as comorbidities 
(including hypertension) may have affected ECG findings; however, patients’ comorbidities as well 
as their medication are part of the “real world” characteristics of individuals presenting with IVNC, 
which may also be reflected in their ECGs. Similarly, ischemic as well as valvular heart disease 
may have affected ECG findings, which, however, most likely represents an integral part of the 
disease process, and may hence readily be encountered in patients presenting with IVNC. 
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Legends to Figures 
 
Figure 1: End-diastolic still frame (close-up view of the left ventricular apex) of a 37 year-old 
female demonstrating LV noncompaction with a thin epicardial and a thickened endocardial layer 
with prominent deep recesses. Blood flow from the ventricular cavity into the recesses is visualized 
on color Doppler imaging. 
 
Figure 2: Most frequent ECG findings at the time of initial diagnosis of IVNC. 
 
Figure 3: ECG of a 43 year-old patient with IVNC showing left bundle branch block, voltage signs 
of left ventricular hypertrophy, prolonged QTc duration (QTc 490msec at heart rate 82/min), and 
(secondary) repolarisation abnormalities. 
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Table 1: Baseline electrocardiographic findings at the time of initial diagnosis of IVNC. 
Number of patients (%) and mean (+/- standard deviation) are shown for categorical and continuous 
data, respectively (Total n = 78). 
 
Characteristic   
Normal study 10 (13%) 
Rhythm  
   Sinus rhythm 74 (95%) 
   Atrial fibrillation / Flutter 3 (4%) 
   AV block III° 2 (3%) 
   Heart rate (bpm)  -   Mean (+/- SD) 76 (+/-18) 
Atrial activation  
   PR interval (msec)  -  Mean (+/- SD) 167 (+/-32) 
   AV block I° 12 (15%) 
   P mitrale 20 (26%) 
   P pulmonale 12 (15%) 
Ventricular depolarization (n=77)  
   QRS duration (msec)  -  Mean (+/- SD) 109 (+/-31) 
   Conduction delay (all) 24 (31%) 
      Right bundle branch block 2 (3%) 
      Left bundle branch block 15 (19%) 
      Nonspecific intraventricular conduction delay 7 (9%) 
   Incomplete right bundle branch block 2 (3%) 
   Left anterior fascicular block 3 (4%) 
   Left posterior fascicular block 0 (0%) 
   QRS "notch" 37 (47%) 
   Ventricular pre-excitation 2 (3%) 
Left ventricular hypertrophy (n=77) 30 (38%) 
Right ventricular hypertrophy (n=77) 5 (6%) 
Repolarisation (n=77)  
   Pathologic repolarisation 56 (72%) 
   ST segment elevation 8 (10%) 
   ST segment depression 40 (51%) 
   T-wave inversion 32 (41%) 
   QTc prolongation 40 (52%) 
   QTc duration (msec)  -  Mean (+/- SD) 455 (+/-52) 
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Table 2: Baseline echocardiographic parameters at the time of initial diagnosis of IVNC. 
Number of patients (%) and mean (+/- standard deviation) are shown for categorical and continuous data, 
respectively (Total n = 78). 
Characteristic    
Pattern of left ventricular segment involvement    
   Apex  70 (90%) 
   Midventricular Septal 5 (6%) 
 Anterior 8 (10%) 
 Lateral 40 (51%) 
Infero-posterior 40 (51%) 
   Basal Septal 0 
 Anterior 0 
 Lateral 5 (6%) 
Infero-posterior 9 (12%) 
Number of affected left ventricular segments   
   1  30 (38%) 
      Isolated apical involvement  29 (37%) 
   2  12 (15%) 
   3  17 (22%) 
   4  9 (12%) 
   5  8 (10%) 
   Average number of affected left ventricular segments  2.40 
Left ventricular ejection fraction (biplane)   
   ≤ 30%  30 (38%) 
   30-50 %  23 (29%) 
   > 50%  25 (32%) 
   Left ventricular ejection fraction (%)  -  Mean (+/- SD)  
40.2 (+/-
18.7) 
Left atrial dilation (Endsystolic diameter ≥ 2.3 cm/m2, 
n=75)  
35 (47%) 
Right atrial dilation (n=74)  31 (42%) 
Left ventricular dilation (Enddiastolic diameter ≥ 3.3 cm/m2, n=72) 26 (36%) 
   Enddiastolic diameter (cm/m2)  -  Mean (+/- SD)  3.3 (+/-0.6) 
Left ventricular hypertrophy (Posterior wall or Septum ≥ 1.2cm; n=72) 13 (18%) 
Regional wall motion abnormalities (n=71)  56 (79%) 
Valvular pathology (n=75)   
   Mitral valve  19 (25%) 
   Aortic valve  13 (17%) 
   Tricuspid valve  4 (5%) 
   Pulmonary valve   0 
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Table 3: Subgroup analysis according to clinical presentation. 
Subgroups are underlined, and characteristics are written in italics. Number of patients (%) with 
characteristic present (Char +) and absent (Char -) are shown.  
 
Subgroup / Characteristic       
 Char + Char - p 
Men    
   Angina pectoris on presentation 15/55 (27%) 1/23 (4%) 0.05 
Presentation with ventricular tachycardia, ventricular fibrillation or asystole   
   Right bundle branch block 2/6 (33%) 0/72 (0%) 0.005 
Presentation with syncope    
   Signs of heart failure 1/11 (9%) 32/67 (48%) 0.02 
   Left ventricular ejection fraction  ≤ 30% 0/11 (0%) 30/67 (45%) 0.01 
   Left ventricular dilation (enddiastolic diameter ≥ 3.3 cm/m2) 0/9 (0%) 26/63 (41%) 0.022 
History of systemic embolism    
   Left ventricular hypertrophy on ECG (voltage criteria) 7/10 (70%) 23/68 (34%) 0.039 
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Table 4: Subgroup analysis according to ECG findings. 
Subgroups are underlined, and characteristics are written in italics. For categorical data, number of 
patients (%) with characteristic present (Char +) and absent (Char -) are shown. For continuous 
data, mean (+/- standard deviation) with characteristic present (Char +) and absent (Char -) are 
provided.  
 
Subgroup / Characteristic       
 Char + Char - p 
Normal ECG    
   Age at diagnosis (years)  -  Mean ± SD 32 ± 9.8 43.5 ± 16.6 <0.05 
   Heart failure on presentation 1/10 (10%) 
32/68 
(47%) 0.037 
   Left ventricular ejection fraction (%)  -  Mean ± SD 58.9 ± 12.5 37.4 ± 17.9 <0.0005 
QRS ≥ 120 msec    
   AV block I° 8/24 (33%) 4/54 (7%) <0.01 
   Age at diagnosis (years)  -  Mean ± SD 49.7 ± 15.9 38.6 ± 15.5 <0.005 
   Heart failure on presentation 
13/24 
(54%) 
13/54 
(24%) <0.01 
   Left ventricular ejection fraction (%)  -  Mean ± SD 31.7 ± 14.9 43.9 ± 19.1 <0.01 
   Left atrial dilation (endsystolic diameter ≥ 2.3 cm/m2) 
17/23 
(74%) 
18/52 
(35%) <0.005 
   Left ventricular dilation (enddiastolic diameter ≥ 3.3 cm/m2) 
12/21 
(57%) 
14/51 
(28%) 0.03 
   Apical involvement 
18/24 
(75%) 
51/54 
(94%) 0.022 
Left ventricular hypertrophy (voltage criteria)    
   Left ventricular ejection fraction (%)  -  Mean ± SD 33.5 ± 17.3 44.3 ± 18.5 <0.02 
   Left ventricular end-diastolic diameter (cm/m2)  -  Mean ± SD 3.48 ± 0.7 3.13 ± 0.5 <0.05 
   Presentation with systemic embolism 5/30 (17%) 1/48 (2%) 0.029 
   History of systemic embolism 7/30 (23%) 3/48 (6%) 0.039 
QTc prolongation    
   Age at diagnosis (years)  -  Mean ± SD 48 ± 14.7 35.7 ± 15.8 <0.001 
   Left ventricular ejection fraction (%)  -  Mean ± SD 32.2 ±15.8 48.5 ± 18 <0.0001 
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Table 5: Subgroup analysis according to echocardiographic findings. 
Subgroups are underlined, and characteristics are written in italics. For categorical variables, 
number of patients (%) with characteristic present (Char +) and absent (Char -) are shown. For 
continuous variables, mean (+/- standard deviation) with characteristic present (Char +) and absent 
(Char -) are provided.  
 
Subgroup / Characteristic    
 Char + Char - p 
Isolated apical involvement    
   Presentation with heart failure 5/29 (17%) 21/49 (43%) 0.026 
Left ventricular ejection fraction ≤ 30%    
   Age at diagnosis (years)  -  Mean ± SD 49.1 ± 13.8 37.6 ± 16.4 <0.005 
   History of syncope / presyncope 0/30 (0%) 11/48 (23%) <0.02 
   AV block I° 10/30 (33%) 2/48 (4%) <0.001 
   Left bundle branch block 10/26 (39%) 5/52 (10%) <0.02 
   QTc duration (msec)  -  Mean ± SD 482.8 ± 45.1 
438.1 ± 
48.3 <0.0002 
Left ventricular dilation (enddiastolic diameter ≥ 3.3 cm/m2)    
   PR duration (msec)  -  Mean ± SD 178.3 ± 23.2 161.4 ± 35 <0.01 
   Left bundle branch block 9/26 (35%) 6/52 (12%) 0.03 
   QTc duration (msec)  -  Mean ± SD 472.1 ± 50.1 
446.8 ± 
50.8 0.045 
   Left ventricular hypertrophy on ECG (voltage criteria) 16/26 (62%) 
14/52 
(27%) <0.01 
Left atrial dilation (endsystolic diameter ≥ 2.3 cm/m2)    
   Normal ECG 1/35 (3%) 9/43 (21%) <0.02 
   AV block I° 9/35 (26%) 3/43 (7%) <0.05 
   Left bundle branch block 11/35 (31%) 4/43 (9.3%) 0.02 
   Left ventricular hypertrophy on ECG (voltage criteria) 18/35 (51%) 
12/43 
(28%) 0.039 
Right atrial dilation    
   PR duration (msec)  -  Mean ± SD 178.8 ± 25.6 160 ± 34.2 <0.005 
Left ventricular hypertrophy (posterior wall or septum ≥ 1.2cm)    
   Age at diagnosis (years)  -  Mean ± SD 52.8 ± 13.4 39.8 ± 16.1 <0.01 
   Apical involvement 9/13 (69%) 60/65 (92%) 0.038 
 
 
 
